SCHEMBL29463176

SCHEMBL29463176

COc1c(C)c2c(c(O)c1C/C=C1\CCC[C@H]1[C@H](C)C(=O)O)C(=O)OC2

nearest known ligand 0.83

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IMPDH1 P20839 17/20 0.83
IMPDH2 P12268 14/20 0.83
KDM4E B2RXH2 1/20 0.55
ALDH1A1 P00352 1/20 0.55
LMNA P02545 1/20 0.55
CYP1A2 P05177 1/20 0.55
CYP3A4 P08684 1/20 0.55
HPGD P15428 1/20 0.55
UGT2B7 P16662 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
HSD17B10 Q99714 1/20 0.55
HDAC3 O15379 1/20 0.50
HDAC4 P56524 1/20 0.50
HDAC1 Q13547 1/20 0.50
HDAC7 Q8WUI4 1/20 0.50
HDAC2 Q92769 1/20 0.50
HDAC10 Q969S8 1/20 0.50
HDAC11 Q96DB2 1/20 0.50
HDAC8 Q9BY41 1/20 0.50
HDAC6 Q9UBN7 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1152729 1.00 IMPDH1 (0.83) IMPDH1IMPDH2KDM4EALDH1A1LMNA
SCHEMBL8206043 1.00 IMPDH1 (0.83) IMPDH1IMPDH2KDM4EALDH1A1LMNA
SCHEMBL8212537 1.00 IMPDH1 (0.83) IMPDH1IMPDH2KDM4EALDH1A1LMNA
SCHEMBL1152849 0.97 IMPDH1 (0.79) IMPDH1IMPDH2KDM4EALDH1A1LMNA
SCHEMBL8206728 0.97 IMPDH1 (0.79) IMPDH1IMPDH2KDM4EALDH1A1LMNA
SCHEMBL8206511 0.97 IMPDH1 (0.79) IMPDH1IMPDH2KDM4EALDH1A1LMNA
SCHEMBL1153350 0.90 IMPDH1 (0.68) IMPDH1IMPDH2KDM4EALDH1A1LMNA
SCHEMBL1152538 0.87 IMPDH1 (0.64) IMPDH1IMPDH2KDM4EALDH1A1LMNA
SCHEMBL9084374 0.84 IMPDH1 (0.60) IMPDH1IMPDH2KDM4EALDH1A1LMNA
SCHEMBL7877371 0.84 IMPDH1 (0.60) IMPDH1IMPDH2KDM4EALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11938137-B2 Lipid prodrugs of mycophenolic acid and uses thereof PURETECH LYT, INC. (US) 2024-03-26 US disclosed
US-20220143038-A1 LIPID PRODRUGS OF MYCOPHENOLIC ACID AND USES THEREOF PURETECH LYT, INC. (US) 2022-05-12 US disclosed
US-11304954-B2 Lipid prodrugs of mycophenolic acid and uses thereof PURETECH LYT, INC. (US) 2022-04-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11938137-B2 Lipid prodrugs of mycophenolic acid and uses thereof MALT1, CYP2B6, LIPA IMPDH1 454/4885IMPDH2 462/4885KDM4E 1491/4885
US-11304954-B2 Lipid prodrugs of mycophenolic acid and uses thereof MALT1, CYP2B6, LIPA IMPDH1 454/4885IMPDH2 462/4885KDM4E 1491/4885
US-20220143038-A1 LIPID PRODRUGS OF MYCOPHENOLIC ACID AND USES THEREOF MALT1, CYP2B6, LIPA IMPDH1 454/4885IMPDH2 462/4885KDM4E 1491/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.